<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Genital Herpes – Quick-Reference Algorithm</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<style>
:root{
    --clr-primary:#0d6efd;
    --clr-danger:#dc3545;
    --clr-success:#198754;
    --clr-bg:#f8f9fa;
    --clr-card:#ffffff;
    --radius:.75rem;
    --shadow:0 2px 8px rgba(0,0,0,.08);
    --font:'Segoe UI',system-ui,Helvetica,Arial,sans-serif;
}
*{margin:0;padding:0;box-sizing:border-box}
body{font-family:var(--font);background:var(--clr-bg);color:#212529;line-height:1.6;padding:2rem}
h1{color:var(--clr-primary);text-align:center;margin-bottom:1.5rem;font-size:2rem}
.container{max-width:960px;margin:auto;display:grid;gap:1.5rem}
.card{background:var(--clr-card);border-radius:var(--radius);padding:1.5rem;box-shadow:var(--shadow)}
.card h2{color:var(--clr-primary);border-bottom:2px solid var(--clr-primary);padding-bottom:.5rem;margin-bottom:1rem;font-size:1.25rem}
.table{display:grid;gap:.5rem}
.row{display:grid;grid-template-columns:1fr 2fr;border:1px solid #dee2e6;border-radius:var(--radius);overflow:hidden}
.row:nth-child(odd){background:#f1f3f5}
.cell{padding:.75rem;font-size:.95rem}
.cell:first-child{font-weight:600;background:var(--clr-primary);color:#fff}
ul{margin-left:1.25rem}
li{margin-bottom:.25rem}
.btn{background:var(--clr-success);color:#fff;padding:.5rem .75rem;border:none;border-radius:var(--radius);text-decoration:none;font-size:.9rem;display:inline-block;margin-top:.5rem}
.alert{background:var(--clr-danger);color:#fff;padding:.5rem .75rem;border-radius:var(--radius);font-weight:600}
@media(max-width:600px){
    .row{grid-template-columns:1fr}
    h1{font-size:1.5rem}
}
</style>
</head>
<body>
<div class="container">
    <h1>Genital Herpes – Quick-Reference Algorithm</h1>

    <!-- 1 -->
    <div class="card">
        <h2>1. Is it Genital Herpes?</h2>
        <div class="table">
            <div class="row">
                <div class="cell">First Episode</div>
                <div class="cell">Painful clustered vesicles → ulcers, bilateral, systemic flu-like, ≤ 3 weeks.</div>
            </div>
            <div class="row">
                <div class="cell">Recurrent</div>
                <div class="cell">Prodrome (tingle/burn 48 h), unilateral, milder, 6–12 days.</div>
            </div>
        </div>
        <p style="margin-top:1rem"><strong>Confirm</strong> with PCR swab (sexual-health clinic preferred).  
        <strong>Diff Dx:</strong> syphilis, shingles, candida, trauma, Behçet.</p>
    </div>

    <!-- 2 -->
    <div class="card">
        <h2>2. Immediate Actions</h2>
        <ul>
            <li><strong>Red flags:</strong> systemically unwell, urinary retention, pregnancy, immunocompromise → <span class="alert">Emergency referral</span></li>
            <li><strong>Counsel:</strong> abstain while lesions/prodrome; condoms reduce but do not abolish risk; screen partners</li>
            <li><strong>Self-care:</strong> saline baths, paracetamol/ibuprofen, lidocaine 5 % gel, dilute urine, loose clothing</li>
        </ul>
    </div>

    <!-- 3 -->
    <div class="card">
        <h2>3. Treatment Pathways</h2>
        <div class="table">
            <div class="row">
                <div class="cell">First Episode</div>
                <div class="cell">Aciclovir 400 mg TDS <strong>or</strong> Valaciclovir 500 mg BD × 5 days (extend to 10 if new lesions)</div>
            </div>
            <div class="row">
                <div class="cell">Recurrent – Episodic</div>
                <div class="cell">Aciclovir 800 mg TDS × 2 days <strong>or</strong> Famciclovir 1 g BD × 1 day <strong>or</strong> Valaciclovir 500 mg BD × 3 days</div>
            </div>
            <div class="row">
                <div class="cell">Recurrent – Suppressive</div>
                <div class="cell">Aciclovir 400 mg BD <strong>or</strong> Valaciclovir 500 mg OD for 1 year, then reassess</div>
            </div>
            <div class="row">
                <div class="cell">Immunocompromise / HIV</div>
                <div class="cell">Double standard dose; 5–10 days; seek specialist if breakthrough lesions</div>
            </div>
        </div>
        <p style="margin-top:.5rem"><strong>Never topical antivirals.</strong></p>
    </div>

    <!-- 4 -->
    <div class="card">
        <h2>4. When to Refer</h2>
        <ul>
            <li>Uncertain diagnosis</li>
            <li>Pregnancy (any gestation)</li>
            <li>Immunocompromise with severe / non-responding lesions</li>
            <li>≥ 6 episodes/yr despite suppressive therapy</li>
        </ul>
    </div>

    <!-- 5 -->
    <div class="card">
        <h2>5. Pregnancy Pearls</h2>
        <ul>
            <li><strong>Primary episode in 3rd trimester</strong> → highest neonatal risk → urgent obstetric & sexual-health liaison</li>
            <li><strong>Recurrent lesions at delivery</strong> → low risk; still inform obstetrics</li>
        </ul>
    </div>

    <!-- Resources -->
    <div class="card" style="text-align:center">
        <h2 style="border:none;margin-bottom:.5rem">Patient Resources</h2>
        <a href="https://www.herpes.org.uk" target="_blank" class="btn">Herpes Viruses Association</a>
        <a href="https://www.fpa.org.uk" target="_blank" class="btn" style="margin-left:.5rem">FPA Leaflet</a>
    </div>
</div>
</body>
</html>